HER2-POSITIVE BREAST CARCINOMA
Clinical trials for HER2-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
BREAST CANCER BREAKTHROUGH: SURGERY AND RADIATION MAY BE AVOIDED IN SOME PATIENTS
Disease control Recruiting nowThis study is testing whether certain breast cancer patients who respond extremely well to initial drug therapy can safely skip surgery or radiation. For HER2-positive and triple-negative breast cancers, if a biopsy shows no cancer left after drug treatment, patients receive only…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:15 UTC
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
AI-Powered scans aim to predict breast cancer remission without surgery
Diagnosis Recruiting nowThis study is testing whether a special PET/MRI scan, analyzed by artificial intelligence, can accurately tell if HER2-positive breast cancer has been completely eliminated by chemotherapy before surgery. Researchers will scan 460 women before, during, and after treatment, then c…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated May 26, 2026 04:11 UTC
-
Breast cancer drug may raise diabetes risk, new study warns
Knowledge-focused Recruiting nowThis study looks at how common hormone therapies for breast cancer affect blood sugar control and diabetes risk in postmenopausal women. Researchers will compare women taking aromatase inhibitors, tamoxifen, or no treatment over one year. The goal is to understand if these treatm…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
Researchers track immune cells in HER2 breast cancer patients
Knowledge-focused Recruiting nowThis study looks at blood and tumor samples from 230 adults with HER2-positive breast cancer (stages I-IV) who are starting anti-HER2 drugs like trastuzumab. The goal is to learn how the immune system reacts to these treatments. No new therapy is being tested; instead, researcher…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC